Background
- Disorder of glucose metabolism resulting in chronically elevated serum glucose levels
Causes and Classification
- Type 1: absolute insulin deficiency from beta-islet cell destruction
- Type 1a: autoimmune beta-islet destruction
- Type 1b: beta-islet destruction without known cause
- Latent autoimmune diabetes in adults (LADA): insulin resistance that progresses to autoimmune diabetes and insulin dependency over several years
- Type 2: insulin resistance and varying degrees of insulin deficiency
- Genetic conditions
- Exocrine pancreas disorders
- Drug-induced
- Stiff-person syndrome
- Anti-insulin receptor antibodies
Management
ABCDESSS
- A1c targets: ≤7% (or ≤6.5 to decrease disk of CKD and retinopathy)
- BP targets: <130/80 mmHg
- Cholesterol targets: LDL <2 mmol/L or >50% reduction from baseline
- Drugs for CVD risk reduction
- ACEi/ARB if CVD, age ≥55 with risk factors, or diabetes complications
- Statin if CVD, age ≥40 (for type 2), or diabetes complications
- ASA if CVD
- SGLT2i/GLP1ra if type 2 with CVD and A1c not at target
- Exercise goals and healthy eating
- 150 minutes of moderate-to-vigorous aerobic activity weekly, with resistance exercise 2-3 times weekly
- Health dietary pattern such as Mediterranean diet or low glycemic index diet
- Screening for complications
- Cardiac: ECG every 3-5 years if age >40 or diabetes complications
- Foot: monofilament or vibration testing yearly, or more often if abnormal
- Kidney: creatinine and ACR yearly, or more often if abnormal
- Retinopathy: yearly for type 1, every 1-2 years for type 2
- Smoking cessation: ask permission to give advice, refer for therapy, and provide support
- Self-management, stress, and other barriers
- Set personalized goals
- Assess for stress, mental health, and financial concerns that might be barriers to achieving goals